Constellation Pharmaceuticals, Inc

(NASDAQ:CNST)

Latest On Constellation Pharmaceuticals, Inc (CNST):

Date/Time Type Description Signal Details
2021-07-21 02:07 ESTNewsMorphoSys to acquire Constellation Pharma for $1.7B in cashN/A
2021-07-21 02:06 ESTNewsEpizyme gains as peer Constellation attracts sizable premium from MorphoSysN/A
2021-07-21 01:52 ESTNewsConstellation Pharma presents mid-stage data for pelabresib in myelofibrosisN/A
2021-07-21 01:45 ESTNewsCureVac downgraded following COVID vaccine data, Regeneron COVID cocktail a boon, and more in analyst actionN/A
2021-07-21 01:31 ESTNewsConstellation Pharmaceuticals says HSR waiting period expired for its planned sale to MorphoSysN/A
2021-07-21 01:11 ESTNewsMorphoSys at a historic low as it completes acquisition of Constellation PharmaN/A
2021-02-26 15:21 ESTFinancialsCompany financials have been released.Neutral
2021-02-26 15:21 ESTAnalyst RatingThe Analyst Target Price has increased from $47.44 to $47.75.Buy
2021-02-25 11:45 ESTEarnings EstimateAn EPS average of -$0.86 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-25 11:45 ESTEarnings EstimateAn EPS average of -$3.75 is estimated for the 2022 year.Sell
2021-02-25 11:45 ESTAnalyst RatingThe Analyst Target Price has decreased from $48.22 to $47.44.Neutral
2021-02-25 00:30 ESTNewsConstellation Pharmaceuticals EPS misses by $0.04N/A
2021-02-25 00:29 ESTNewsConstellation Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-02-25 00:29 ESTNewsConstellation Pharmaceuticals, Inc. (CNST) CEO Jigar Raythatha on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-25 00:28 ESTNewsConstellation Pharma falls after Q4 earnings failed to meet consensusN/A
2021-01-26 07:23 ESTAnalyst RatingThe Analyst Target Price has increased from $45.67 to $48.22.Buy
2021-01-21 22:41 ESTNewsConstellation Pharma: CPI-0610 Is Well-Differentiated In The Myelofibrosis Treatment Development PipelineN/A
2021-01-07 09:45 ESTNewsConstellation Pharmaceuticals appoints new chief commercial officerN/A
2021-01-05 11:29 ESTAnalyst RatingThe Analyst Target Price has increased from $44.89 to $45.67.Buy
2020-12-13 03:38 ESTFinancialsCompany financials have been released.Neutral
2020-12-09 11:35 ESTAnalyst RatingThe Analyst Target Price has increased from $44.56 to $44.89.Buy
2020-12-08 11:30 ESTAnalyst RatingThe Analyst Target Price has increased from $44.22 to $44.56.Buy
2020-12-06 23:12 ESTNewsEyes on Constellation Pharma after ASH conference presentation on CPI-0610 for myelofibrosisN/A
2020-11-17 11:28 ESTAnalyst RatingThe Analyst Target Price has increased from $44 to $44.22.Buy
2020-11-07 15:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-03 07:37 ESTAnalyst RatingThe Analyst Target Price has increased from $43.45 to $44.Buy
2020-11-02 07:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-02 03:25 ESTAnalyst RatingThe Analyst Target Price has decreased from $43.55 to $43.45.Neutral
2020-11-01 18:10 ESTNewsConstellation Pharmaceuticals, Inc. (CNST) CEO Jigar Raythatha on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-01 17:34 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 20:33 ESTEarnings EstimateAn EPS average of -$0.86 is estimated for the quarter ending on March 31, 2021.Sell
2020-10-30 20:33 ESTAnalyst RatingThe Analyst Target Price has decreased from $44.8 to $43.55.Neutral
2020-10-30 14:41 ESTNewsConstellation Pharmaceuticals EPS misses by $0.02N/A
2020-10-30 14:38 ESTNewsConstellation Pharmaceuticals, Inc. 2020 Q3 - Results - Earnings Call PresentationN/A
2020-10-03 08:35 ESTAnalyst RatingThe Analyst Target Price has decreased from $45.8 to $44.8.Neutral
2020-09-30 01:45 ESTNewsConstellation Pharmaceuticals: Myelofibrosis Treatment Win Can Still Happen - We'll Know SoonN/A
2020-09-21 17:58 ESTNewsBuy the dip in biotechs - RBCN/A
2020-09-19 08:39 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:30 ESTFinancialsCompany financials have been released.Neutral
2020-09-09 16:17 ESTNewsConstellation Pharma downgraded to Perform at OppenheimerN/A
2020-09-09 04:31 ESTAnalyst RatingThe Analyst Target Price has decreased from $48.5 to $45.8.Neutral
2020-09-04 08:26 ESTAnalyst RatingThe Analyst Target Price has decreased from $50.22 to $48.5.Neutral
2020-08-10 09:38 ESTNewsConstellation Pharmaceuticals, Inc. (CNST) CEO Jigar Raythatha on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-07 16:27 ESTAnalyst RatingThe Analyst Target Price has decreased from $51.38 to $50.22.Neutral
2020-08-07 08:26 ESTFinancialsCompany financials have been released.Neutral
2020-08-05 10:31 ESTNewsConstellation Pharmaceuticals EPS misses by $0.07N/A
2020-07-31 00:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-24 04:24 ESTAnalyst RatingThe Analyst Target Price has decreased from $52.63 to $51.38.Neutral
2020-07-23 16:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-10 08:29 ESTFinancialsCompany financials have been released.Neutral

About Constellation Pharmaceuticals, Inc (CNST):

Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. The company's lead product candidates include Pelabresib that is in Phase 3 clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib. It is also developing CPI-0209 that is in Phase 1 dose escalation portion of a Phase 1/2 clinical trial to treat solid tumors; and CPI-482, which is in preclinical stage for cancer patients. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008. Constellation Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

CNST Quotes by TradingView

See Advanced Chart

General

  • Name Constellation Pharmaceuticals, Inc
  • Symbol CNST
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 154
  • Fiscal Year EndDecember
  • IPO Date2018-07-19
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.constellationpharma.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 3.45
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.36
  • Next Year EPS Estimate -$3.72
  • Next Quarter EPS Estimate -$0.81
  • Return on Assets -19%
  • Return on Equity -34%
  • Earnings Per Share -$3.13
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.3 billion
  • EBITDA -77339000
  • Analyst Target Price $47.75
  • Book Value Per Share $8.60
View More

Share Statistics

  • Shares Outstanding 47.86 million
  • Shares Float 32.53 million
  • % Held by Insiders 75%
  • % Held by Institutions 104.22%
  • Shares Short 6.11 million
  • Shares Short Prior Month 5.79 million
  • Short Ratio 13.29
  • Short % of Float 19%
  • Short % of Shares Outstanding 13%
View More

Technicals

  • Beta 2.71
  • 52 Week High $50.9
  • 52 Week Low $17
  • 50 Day Moving Average 31.36
  • 200 Day Moving Average 26.79
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Constellation Pharmaceuticals, Inc (CNST) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Constellation Pharmaceuticals, Inc (CNST) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A-$0.79-$0.76-4.59%
2020-09-302020-10-29$N/A-$0.71-$0.65-9.2%
2020-06-302020-08-05$N/A-$0.70-$0.63-10.16%
2020-03-312020-05-06$N/A-$0.61-$0.656.27%
2019-12-312020-03-10$N/A-$0.69-$0.723.94%
2019-09-302019-11-06$N/A-$0.82-$0.82-0.26%
2019-06-302019-08-07$N/A-$0.80-$0.800.01%
2019-03-312019-05-08$N/A-$0.75-$0.806.25%
2018-12-312019-03-14$N/A-$0.77-$0.74-4.36%
2018-09-302018-11-08$N/A-$0.81-$0.68-18.75%
2018-06-302018-08-14$N/A-$0.55-$0.561.84%

Constellation Pharmaceuticals, Inc (CNST) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development -27.36 million N/A 22.63 million 20.08 million 18.59 million
Income Before Tax -37.38 million N/A -29.73 million -25.43 million -24.18 million
Selling General Administrative -8.54 million N/A 6.96 million 5.91 million 5.47 million
Gross Profit N/A N/A N/A N/A N/A
Ebit -37.22 million N/A -28.75 million -24.43 million -24.06 million
Operating Income -35.9 million N/A -29.59 million N/A -24.06 million
Income Tax Expense N/A N/A 24000 15000 24000
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A 29000 N/A -127000
Net Income From Continuing Operations -37.38 million N/A -29.75 million N/A -24.21 million
Net Income Applicable to Common Shares -37.38 million -33.78 million -29.75 million -25.44 million -24.21 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A -172.55 million -118.75 million -39.47 million 33.08 million
Change to Liabilities 239000 1.52 million N/A 2.36 million -1.42 million
Total Cash Flow from Investing Activities -31.77 million -172.55 million N/A -39.48 million 32.87 million
Net Borrowings N/A N/A N/A 1000 10 million
Total Cash Flow from Financial Activities N/A 182.23 million N/A 311.8 million 10.18 million
Change to Operating Activities -1.91 million 3.49 million N/A 2.7 million 1.29 million
Change in Cash N/A -11.35 million N/A 255.36 million 23.93 million
Total Cash from Operating Activities -30.81 million -21.03 million -26.03 million -16.96 million -19.11 million
Depreciation N/A 120000 147000 194000 200000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A 200 -200
Change to Net Income 4.47 million 3.59 million N/A 2 million 1.97 million
Capital Expenditures N/A 123000 N/A 16000 214000
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 31.13 million N/A N/A N/A 61.55 million
Total Stockholder Equity 410.72 million N/A N/A N/A 337.58 million
Other Current Liabilities 3.64 million 420000 N/A 423000 497000
Total Assets 441.85 million N/A N/A 373.06 million 399.13 million
Common Stock 5000 5000 5000 315.53 million 4000
Other Current Assets 7.16 million N/A N/A N/A N/A
Retained Earnings -445.74 million -408.36 million -374.58 million -344.83 million -319.39 million
Other Liabilities N/A 879000 716000 8.57 million 390000
Other Assets 8.21 million 878000 878000 11.4 million 425000
Cash 163.69 million N/A N/A N/A 334.33 million
Total Current Liabilities 30.55 million 31.27 million N/A 19.29 million 22.76 million
Other Stockholder Equity 3000 134000 255000 N/A -6000
Property, Plant & Equipment 1.5 million 10.11 million 10.82 million N/A 11.72 million
Total Current Assets 428.61 million 494.47 million N/A 361.67 million 386.99 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 410.72 million 442.77 million 471.98 million 315.53 million 337.58 million
Short Term Investments 257.76 million N/A N/A N/A 49.6 million
Long Term Debt N/A N/A N/A 29.68 million 29.64 million
Inventory N/A N/A N/A N/A N/A
Accounts Payable 26.9 million 5.37 million N/A N/A 7.28 million

Constellation Pharmaceuticals, Inc (CNST) Chart:

Constellation Pharmaceuticals, Inc (CNST) News:

Below you will find a list of latest news for Constellation Pharmaceuticals, Inc (CNST) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Constellation Pharmaceuticals, Inc (CNST) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Constellation Pharmaceuticals, Inc (CNST) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000119312520177668/0001193125-20-177668-index.htm
2019-08-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1434418/000000000019012251/0000000000-19-012251-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000031506619000937/0000315066-19-000937-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000031506620000883/0000315066-20-000883-index.htm
2018-08-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924318023212/0000899243-18-023212-index.htm
2018-08-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924318023214/0000899243-18-023214-index.htm
2018-09-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924318023858/0000899243-18-023858-index.htm
2018-09-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924318023859/0000899243-18-023859-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924318023860/0000899243-18-023860-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924318023861/0000899243-18-023861-index.htm
2018-11-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924318029880/0000899243-18-029880-index.htm
2018-11-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924318029881/0000899243-18-029881-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924318031227/0000899243-18-031227-index.htm
2019-02-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319004312/0000899243-19-004312-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319004314/0000899243-19-004314-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319006918/0000899243-19-006918-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319006921/0000899243-19-006921-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319006922/0000899243-19-006922-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319006924/0000899243-19-006924-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319006926/0000899243-19-006926-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319016201/0000899243-19-016201-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319016202/0000899243-19-016202-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319016205/0000899243-19-016205-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319016208/0000899243-19-016208-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319016209/0000899243-19-016209-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924319016210/0000899243-19-016210-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924320004897/0000899243-20-004897-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924320004899/0000899243-20-004899-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924320004902/0000899243-20-004902-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924320004905/0000899243-20-004905-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924320004906/0000899243-20-004906-index.htm
2020-04-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924320010269/0000899243-20-010269-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000089924320010271/0000899243-20-010271-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000090266420001120/0000902664-20-001120-index.htm
2018-10-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000091957418006916/0000919574-18-006916-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000091957419001626/0000919574-19-001626-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000091957420000800/0000919574-20-000800-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000092963819000276/0000929638-19-000276-index.htm
2019-11-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000092963819001007/0000929638-19-001007-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000092963820000323/0000929638-20-000323-index.htm
2019-10-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000110465919053426/0001104659-19-053426-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000110465920021700/0001104659-20-021700-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000114036119020387/0001140361-19-020387-index.htm
2019-11-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000114036119020486/0001140361-19-020486-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000114036120003409/0001140361-20-003409-index.htm
2020-06-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000117266120001428/0001172661-20-001428-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434418/000119312518248533/0001193125-18-248533-index.htm
2018-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312518266308/0001193125-18-266308-index.htm
2018-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312518297014/0001193125-18-297014-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312518314734/0001193125-18-314734-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434418/000119312518322731/0001193125-18-322731-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312518322833/0001193125-18-322833-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312518346221/0001193125-18-346221-index.htm
2018-12-178-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312518351075/0001193125-18-351075-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519001051/0001193125-19-001051-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519003053/0001193125-19-003053-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000119312519037920/0001193125-19-037920-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000119312519038142/0001193125-19-038142-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519044702/0001193125-19-044702-index.htm
2019-03-138-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519073339/0001193125-19-073339-index.htm
2019-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519075032/0001193125-19-075032-index.htm
2019-03-15S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1434418/000119312519075040/0001193125-19-075040-index.htm
2019-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519081421/0001193125-19-081421-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519094135/0001193125-19-094135-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1434418/000119312519120839/0001193125-19-120839-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1434418/000119312519120847/0001193125-19-120847-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519141449/0001193125-19-141449-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519148122/0001193125-19-148122-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519148650/0001193125-19-148650-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519169269/0001193125-19-169269-index.htm
2019-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519176481/0001193125-19-176481-index.htm
2019-08-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1434418/000119312519212122/0001193125-19-212122-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519215332/0001193125-19-215332-index.htm
2019-08-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1434418/000119312519220977/0001193125-19-220977-index.htm
2019-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519250697/0001193125-19-250697-index.htm
2019-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519253141/0001193125-19-253141-index.htm
2019-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519259252/0001193125-19-259252-index.htm
2019-10-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000119312519265898/0001193125-19-265898-index.htm
2019-10-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000119312519266785/0001193125-19-266785-index.htm
2019-12-09S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1434418/000119312519309197/0001193125-19-309197-index.htm
2019-12-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1434418/000119312519309266/0001193125-19-309266-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519309320/0001193125-19-309320-index.htm
2019-12-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1434418/000119312519311620/0001193125-19-311620-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312519311623/0001193125-19-311623-index.htm
2019-12-17S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1434418/000119312519316267/0001193125-19-316267-index.htm
2020-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312520001448/0001193125-20-001448-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312520006011/0001193125-20-006011-index.htm
2020-03-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1434418/000119312520068792/0001193125-20-068792-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312520098890/0001193125-20-098890-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312520134889/0001193125-20-134889-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312520142254/0001193125-20-142254-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312520160691/0001193125-20-160691-index.htm
2020-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312520162823/0001193125-20-162823-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1434418/000119312520169318/0001193125-20-169318-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312520169325/0001193125-20-169325-index.htm
2020-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1434418/000119312520171466/0001193125-20-171466-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434418/000119312520171476/0001193125-20-171476-index.htm
2020-06-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434418/000119312520177668/0001193125-20-177668-index.htm
2020-03-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000120919120020724/0001209191-20-020724-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000120919120020728/0001209191-20-020728-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000120919120020732/0001209191-20-020732-index.htm
2019-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000123924119000001/0001239241-19-000001-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000123924119000002/0001239241-19-000002-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000134776919000016/0001347769-19-000016-index.htm
2019-10-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000143441819000001/0001434418-19-000001-index.htm
2019-10-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218019005221/0001562180-19-005221-index.htm
2019-10-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218019005222/0001562180-19-005222-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218019005371/0001562180-19-005371-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218019005372/0001562180-19-005372-index.htm
2019-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218019005397/0001562180-19-005397-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218019005409/0001562180-19-005409-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218019005410/0001562180-19-005410-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218019005412/0001562180-19-005412-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218019005413/0001562180-19-005413-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/0001562180-19-005422-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020001122/0001562180-20-001122-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020001123/0001562180-20-001123-index.htm
2020-02-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020001187/0001562180-20-001187-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020001250/0001562180-20-001250-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020001251/0001562180-20-001251-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020002396/0001562180-20-002396-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020002990/0001562180-20-002990-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020002991/0001562180-20-002991-index.htm
2020-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003027/0001562180-20-003027-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003062/0001562180-20-003062-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003063/0001562180-20-003063-index.htm
2020-04-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003096/0001562180-20-003096-index.htm
2020-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003207/0001562180-20-003207-index.htm
2020-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003210/0001562180-20-003210-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003451/0001562180-20-003451-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003452/0001562180-20-003452-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003453/0001562180-20-003453-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003454/0001562180-20-003454-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003563/0001562180-20-003563-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003587/0001562180-20-003587-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003588/0001562180-20-003588-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003589/0001562180-20-003589-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020003590/0001562180-20-003590-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020004331/0001562180-20-004331-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020004332/0001562180-20-004332-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020004333/0001562180-20-004333-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020004334/0001562180-20-004334-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020004335/0001562180-20-004335-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020004418/0001562180-20-004418-index.htm
2020-07-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020005076/0001562180-20-005076-index.htm
2020-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000156218020005078/0001562180-20-005078-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1434418/000156459019007860/0001564590-19-007860-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434418/000156459019017259/0001564590-19-017259-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434418/000156459019030102/0001564590-19-030102-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434418/000156459019040708/0001564590-19-040708-index.htm
2020-03-1010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1434418/000156459020009735/0001564590-20-009735-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1434418/000156459020018513/0001564590-20-018513-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1434418/000156459020018518/0001564590-20-018518-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434418/000156459020021953/0001564590-20-021953-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434418/000156459020036390/0001564590-20-036390-index.htm
2020-10-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434418/000156459020048495/0001564590-20-048495-index.htm
2019-10-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000173804819000001/0001738048-19-000001-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434418/000173804819000002/0001738048-19-000002-index.htm
2019-08-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1434418/999999999519001904/9999999995-19-001904-index.htm

Constellation Pharmaceuticals, Inc (CNST) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Constellation Pharmaceuticals, Inc (CNST). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 75%
Institutional Ownership: 10422%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-11-05Emma ReeveChief Financial OfficerSell1,000.0015.5015,504.000.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005397/0001562180-19-005397-index.htm
2019-11-06Emma ReeveChief Financial OfficerSell726.0030.8422,389.840.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005413/0001562180-19-005413-index.htm
2020-02-10Emma ReeveChief Financial OfficerSell200.0035.007,000.000.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001123/0001562180-20-001123-index.htm
2020-02-11Emma ReeveChief Financial OfficerSell7,212.0035.04252,708.480.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001123/0001562180-20-001123-index.htm
2020-02-12Emma ReeveChief Financial OfficerSell1,103.0035.0238,623.970.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001251/0001562180-20-001251-index.htm
2020-02-13Emma ReeveChief Financial OfficerSell5,521.0035.06193,539.210.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001251/0001562180-20-001251-index.htm
2020-04-09Emma ReeveChief Financial OfficerSell111.0035.023,886.990.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020002990/0001562180-20-002990-index.htm
2020-04-14Emma ReeveChief Financial OfficerSell1,225.0035.2043,122.700.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003027/0001562180-20-003027-index.htm
2020-04-17Emma ReeveChief Financial OfficerSell760.0035.2926,819.640.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003063/0001562180-20-003063-index.htm
2020-05-08Emma ReeveChief Financial OfficerSell12,741.0049.53631,055.360.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003563/0001562180-20-003563-index.htm
2020-05-11Emma ReeveChief Financial OfficerSell16,062.0049.53795,623.140.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003563/0001562180-20-003563-index.htm
2020-06-08Emma ReeveChief Financial OfficerSell233.0038.358,936.460.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020004418/0001562180-20-004418-index.htm
2020-02-10Karen ValentineOfficerSell14,096.0033.51472,356.960.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001122/0001562180-20-001122-index.htm
2020-02-11Karen ValentineOfficerSell8,550.0035.03299,506.500.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001122/0001562180-20-001122-index.htm
2020-02-12Karen ValentineOfficerSell1,500.0035.0252,527.000.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001250/0001562180-20-001250-index.htm
2020-02-13Karen ValentineOfficerSell4,473.0035.07156,858.720.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001250/0001562180-20-001250-index.htm
2020-03-09Karen ValentineOfficerSell130.0032.924,279.050.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020002396/0001562180-20-002396-index.htm
2020-04-09Karen ValentineOfficerSell635.0035.0222,236.240.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020002991/0001562180-20-002991-index.htm
2020-04-16Karen ValentineOfficerSell1,043.0034.0935,552.010.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003062/0001562180-20-003062-index.htm
2020-04-17Karen ValentineOfficerSell2,300.0035.1980,939.300.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003062/0001562180-20-003062-index.htm
2020-04-20Karen ValentineOfficerSell789.0033.6526,550.090.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003096/0001562180-20-003096-index.htm
2020-04-27Karen ValentineOfficerSell400.0040.1316,052.000.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003207/0001562180-20-003207-index.htm
2020-05-05Karen ValentineOfficerSell4,744.0040.01189,817.400.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003453/0001562180-20-003453-index.htm
2020-05-06Karen ValentineOfficerSell12,566.0040.10503,896.600.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003453/0001562180-20-003453-index.htm
2019-11-06Patrick TrojerChief Scientific OfficerSell11,535.0030.16347,842.540.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005412/0001562180-19-005412-index.htm
2020-05-06Patrick TrojerChief Scientific OfficerSell10,000.0045.16451,553.000.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003454/0001562180-20-003454-index.htm
2019-11-05Emma ReeveChief Financial OfficerBuy1,000.006.616,610.001,000.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005397/0001562180-19-005397-index.htm
2020-05-06Patrick TrojerChief Scientific OfficerBuy2,836.005.6215,938.3210,000.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003454/0001562180-20-003454-index.htm
2019-11-06Jigar RaythathaOfficerSell17,380.0020.18350,726.66100,331.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005409/0001562180-19-005409-index.htm
2020-05-06Karen ValentineOfficerBuy10,099.0011.50116,138.5010,099.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003453/0001562180-20-003453-index.htm
2020-04-16Karen ValentineOfficerSell1,955.0033.2965,085.271,043.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003062/0001562180-20-003062-index.htm
2020-02-12Emma ReeveChief Financial OfficerBuy1,103.008.048,868.121,103.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001251/0001562180-20-001251-index.htm
2020-04-09Emma ReeveChief Financial OfficerBuy111.008.76972.36111.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020002990/0001562180-20-002990-index.htm
2019-11-06Patrick TrojerChief Scientific OfficerSell23,072.0025.06578,214.3111,535.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005412/0001562180-19-005412-index.htm
2019-11-06Jigar RaythathaOfficerBuy102,750.005.51566,152.50117,711.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005409/0001562180-19-005409-index.htm
2020-04-14Emma ReeveChief Financial OfficerBuy1,225.008.7610,731.001,225.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003027/0001562180-20-003027-index.htm
2020-05-06Karen ValentineOfficerBuy2,467.008.7621,610.9212,566.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003453/0001562180-20-003453-index.htm
2020-05-08Emma ReeveChief Financial OfficerBuy6,656.0011.5076,544.0012,741.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003563/0001562180-20-003563-index.htm
2020-03-09Karen ValentineOfficerSell335.0032.0810,746.30130.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020002396/0001562180-20-002396-index.htm
2020-05-11Emma ReeveChief Financial OfficerBuy10,736.008.7694,047.3613,364.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003563/0001562180-20-003563-index.htm
2020-02-10Karen ValentineOfficerBuy14,096.0011.50162,104.0014,096.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001122/0001562180-20-001122-index.htm
2020-02-11Emma ReeveChief Financial OfficerBuy1,430.008.0411,497.201,430.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001123/0001562180-20-001123-index.htm
2020-04-27MARK A GOLDSMITHDirectorSell400.0040.1216,049.00143,063.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003210/0001562180-20-003210-index.htm
2020-05-05MARK A GOLDSMITHDirectorSell3,145.0040.01125,823.90143,063.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003451/0001562180-20-003451-index.htm
2020-05-06MARK A GOLDSMITHDirectorSell11,463.0045.06516,544.56143,063.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003451/0001562180-20-003451-index.htm
2020-05-11MARK A GOLDSMITHDirectorSell100.0050.005,000.00143,063.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003588/0001562180-20-003588-index.htm
2020-05-12MARK A GOLDSMITHDirectorSell4,225.0050.05211,474.35143,063.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003588/0001562180-20-003588-index.htm
2020-05-11MARK A GOLDSMITHDirectorBuy100.001.55155.00143,163.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003588/0001562180-20-003588-index.htm
2020-04-27MARK A GOLDSMITHDirectorBuy400.001.55620.00143,463.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003210/0001562180-20-003210-index.htm
2019-10-22Patrick TrojerChief Scientific OfficerBuy4,159.005.6223,373.5814,436.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005222/0001562180-19-005222-index.htm
2020-05-05MARK A GOLDSMITHDirectorBuy2,325.001.553,603.75145,388.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003451/0001562180-20-003451-index.htm
2020-05-11Emma ReeveChief Financial OfficerBuy1,178.007.608,952.8014,542.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003563/0001562180-20-003563-index.htm
2020-05-05MARK A GOLDSMITHDirectorBuy300.0011.503,450.00145,688.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003451/0001562180-20-003451-index.htm
2020-05-12MARK A GOLDSMITHDirectorBuy2,625.001.554,068.75145,688.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003588/0001562180-20-003588-index.htm
2020-05-12MARK A GOLDSMITHDirectorBuy300.0011.503,450.00145,988.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003588/0001562180-20-003588-index.htm
2020-05-05MARK A GOLDSMITHDirectorBuy520.007.603,952.00146,208.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003451/0001562180-20-003451-index.htm
2020-05-12MARK A GOLDSMITHDirectorBuy1,300.007.609,880.00147,288.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003588/0001562180-20-003588-index.htm
2019-11-06Jigar RaythathaOfficerSell350.0036.0112,602.4914,961.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005409/0001562180-19-005409-index.htm
2020-05-11Jigar RaythathaOfficerSell26.0050.001,300.0014,961.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003587/0001562180-20-003587-index.htm
2020-05-12Jigar RaythathaOfficerSell9,209.0050.17461,981.4614,961.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003587/0001562180-20-003587-index.htm
2020-05-11Jigar RaythathaOfficerBuy26.005.51143.2614,987.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003587/0001562180-20-003587-index.htm
2020-05-06MARK A GOLDSMITHDirectorBuy6,813.001.5510,560.15149,876.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003451/0001562180-20-003451-index.htm
2020-02-12Karen ValentineOfficerBuy1,500.0011.5017,250.001,500.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001250/0001562180-20-001250-index.htm
2020-05-06MARK A GOLDSMITHDirectorBuy750.0011.508,625.00150,626.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003451/0001562180-20-003451-index.htm
2019-10-22Patrick TrojerChief Scientific OfficerBuy820.005.514,518.2015,256.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005222/0001562180-19-005222-index.htm
2019-11-06Jigar RaythathaOfficerSell20,200.0035.23711,579.3415,311.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005409/0001562180-19-005409-index.htm
2020-05-06MARK A GOLDSMITHDirectorBuy3,900.007.6029,640.00154,526.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003451/0001562180-20-003451-index.htm
2018-12-13Adrian SenderowiczChief Medical OfficerBuy6,801.005.5137,473.5115,884.00https://www.sec.gov/Archives/edgar/data/1434418/000089924318031227/0000899243-18-031227-index.htm
2019-11-06Adrian SenderowiczChief Medical OfficerSell5,451.0035.11191,394.4215,884.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/0001562180-19-005422-index.htm
2020-05-12Adrian SenderowiczChief Medical OfficerSell9,357.0050.18469,488.4115,884.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003589/0001562180-20-003589-index.htm
2019-10-03GROUP L P COLUMN10% Share HolderBuy80,000.008.50680,000.00159,155.00https://www.sec.gov/Archives/edgar/data/1434418/000134776919000016/0001347769-19-000016-index.htm
2020-05-11Emma ReeveChief Financial OfficerBuy1,520.006.6110,047.2016,062.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003563/0001562180-20-003563-index.htm
2019-11-06Emma ReeveChief Financial OfficerSell11,976.0020.01239,631.3816,466.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005413/0001562180-19-005413-index.htm
2019-10-22Patrick TrojerChief Scientific OfficerBuy2,370.004.089,669.6017,626.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005222/0001562180-19-005222-index.htm
2019-11-06Patrick TrojerChief Scientific OfficerBuy8,641.005.5147,611.9117,859.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005412/0001562180-19-005412-index.htm
2019-10-22Patrick TrojerChief Scientific OfficerBuy581.007.604,415.6018,207.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005222/0001562180-19-005222-index.htm
2020-02-13Karen ValentineOfficerBuy1,906.008.7616,696.561,906.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001250/0001562180-20-001250-index.htm
2020-02-10Emma ReeveChief Financial OfficerBuy200.007.601,520.00200.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001123/0001562180-20-001123-index.htm
2019-11-12OF THE UNIVERSITY OF CALIFORNIA REGENTS10% Share HolderSell12,800.0032.77419,456.002,111,290.00https://www.sec.gov/Archives/edgar/data/1434418/000114036119020387/0001140361-19-020387-index.htm
2019-11-08OF THE UNIVERSITY OF CALIFORNIA REGENTS10% Share HolderSell74,316.0030.442,262,179.042,127,090.00https://www.sec.gov/Archives/edgar/data/1434418/000114036119020387/0001140361-19-020387-index.htm
2019-11-06Adrian SenderowiczChief Medical OfficerSell10,899.0030.14328,536.1921,335.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/0001562180-19-005422-index.htm
2019-11-08OF THE UNIVERSITY OF CALIFORNIA REGENTS10% Share HolderSell1,000,000.0030.2530,250,000.002,197,406.00https://www.sec.gov/Archives/edgar/data/1434418/000114036119020387/0001140361-19-020387-index.htm
2020-04-17Karen ValentineOfficerBuy2,300.0011.5026,450.002,300.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003062/0001562180-20-003062-index.htm
2020-06-08Emma ReeveChief Financial OfficerSell144.0037.675,423.88233.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020004418/0001562180-20-004418-index.htm
2020-05-12Jigar RaythathaOfficerBuy9,209.005.5150,741.5924,170.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003587/0001562180-20-003587-index.htm
2020-05-12Adrian SenderowiczChief Medical OfficerBuy9,357.005.5151,557.0725,241.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003589/0001562180-20-003589-index.htm
2020-05-12James E AudiaDirectorSell6,100.0050.10305,621.5925,434.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003590/0001562180-20-003590-index.htm
2020-05-11Emma ReeveChief Financial OfficerBuy2,628.0011.5030,222.002,628.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003563/0001562180-20-003563-index.htm
2019-11-06Emma ReeveChief Financial OfficerSell6,188.0019.20118,838.6828,442.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005413/0001562180-19-005413-index.htm
2020-04-16Karen ValentineOfficerBuy2,998.0011.5034,477.002,998.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003062/0001562180-20-003062-index.htm
2020-05-06James E AudiaDirectorSell7,500.0045.15338,599.5031,534.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003452/0001562180-20-003452-index.htm
2019-11-06Adrian SenderowiczChief Medical OfficerSell5,451.0025.18137,255.6332,234.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/0001562180-19-005422-index.htm
2019-11-06Patrick TrojerChief Scientific OfficerSell11,535.0020.01230,796.8934,607.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005412/0001562180-19-005412-index.htm
2019-11-06Emma ReeveChief Financial OfficerSell24,264.0018.40446,518.2634,630.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005413/0001562180-19-005413-index.htm
2019-11-06Jigar RaythathaOfficerSell12,095.0031.32378,794.8435,511.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005409/0001562180-19-005409-index.htm
2019-11-06Patrick TrojerChief Scientific OfficerBuy18,765.005.62105,459.3036,624.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005412/0001562180-19-005412-index.htm
2019-11-06Adrian SenderowiczChief Medical OfficerSell5,431.0020.01108,662.3637,685.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/0001562180-19-005422-index.htm
2020-06-08Emma ReeveChief Financial OfficerSell212.0036.597,757.23377.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020004418/0001562180-20-004418-index.htm
2019-11-06James E AudiaDirectorSell7,500.0019.11143,356.5039,034.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005410/0001562180-19-005410-index.htm
2020-04-27Karen ValentineOfficerBuy400.0011.504,600.00400.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003207/0001562180-20-003207-index.htm
2019-12-13Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy400,000.0034.5013,800,000.004,016,873.00https://www.sec.gov/Archives/edgar/data/1434418/000173804819000002/0001738048-19-000002-index.htm
2019-11-06Patrick TrojerChief Scientific OfficerBuy5,786.007.6043,973.6042,410.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005412/0001562180-19-005412-index.htm
2019-11-06Adrian SenderowiczChief Medical OfficerBuy27,232.005.51150,048.3243,116.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005422/0001562180-19-005422-index.htm
2019-11-06Patrick TrojerChief Scientific OfficerBuy839.007.606,376.4043,249.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005412/0001562180-19-005412-index.htm
2020-02-13Karen ValentineOfficerBuy2,567.0011.5029,520.504,473.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001250/0001562180-20-001250-index.htm
2019-11-06Patrick TrojerChief Scientific OfficerBuy2,893.008.0423,259.7246,142.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005412/0001562180-19-005412-index.htm
2020-03-09Karen ValentineOfficerSell152.0031.174,737.90465.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020002396/0001562180-20-002396-index.htm
2019-11-06James E AudiaDirectorSell10,500.0018.58195,076.3546,534.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005410/0001562180-19-005410-index.htm
2020-05-05Karen ValentineOfficerBuy4,744.0011.5054,556.004,744.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003453/0001562180-20-003453-index.htm
2019-11-06Jigar RaythathaOfficerSell29,005.0030.19875,527.5347,606.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005409/0001562180-19-005409-index.htm
2019-10-03ANTHONY B EVNINDirectorBuy2,823,529.008.5023,999,996.505,342,765.00https://www.sec.gov/Archives/edgar/data/1434418/000123924119000001/0001239241-19-000001-index.htm
2020-02-13Emma ReeveChief Financial OfficerBuy5,521.008.0444,388.845,521.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001251/0001562180-20-001251-index.htm
2019-11-06Emma ReeveChief Financial OfficerBuy56,542.006.61373,742.6256,542.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005413/0001562180-19-005413-index.htm
2019-11-06James E AudiaDirectorSell4,500.0017.5578,978.1557,034.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005410/0001562180-19-005410-index.htm
2019-12-13ANTHONY B EVNINDirectorBuy400,000.0034.5013,800,000.005,742,765.00https://www.sec.gov/Archives/edgar/data/1434418/000123924119000002/0001239241-19-000002-index.htm
2019-11-06Emma ReeveChief Financial OfficerSell4,158.0017.5973,157.9358,894.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005413/0001562180-19-005413-index.htm
2020-04-09Emma ReeveChief Financial OfficerBuy589.007.604,476.40589.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020002990/0001562180-20-002990-index.htm
2020-06-08Emma ReeveChief Financial OfficerBuy589.007.604,476.40589.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020004418/0001562180-20-004418-index.htm
2019-10-03GROUP L P COLUMN10% Share HolderBuy1,331,764.008.5011,319,994.006,009,702.00https://www.sec.gov/Archives/edgar/data/1434418/000134776919000016/0001347769-19-000016-index.htm
2020-03-19GROUP L P COLUMN10% Share HolderBuy36,135.0022.38808,701.306,045,837.00https://www.sec.gov/Archives/edgar/data/1434418/000120919120020732/0001209191-20-020732-index.htm
2020-03-20GROUP L P COLUMN10% Share HolderBuy5,539.0023.15128,227.856,051,376.00https://www.sec.gov/Archives/edgar/data/1434418/000120919120020732/0001209191-20-020732-index.htm
2020-05-08Emma ReeveChief Financial OfficerBuy6,085.008.0448,923.406,085.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003563/0001562180-20-003563-index.htm
2019-11-05James E AudiaDirectorSell2,288.0015.0134,350.8961,534.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005372/0001562180-19-005372-index.htm
2020-03-09Karen ValentineOfficerBuy617.008.765,404.92617.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020002396/0001562180-20-002396-index.htm
2019-11-06Emma ReeveChief Financial OfficerSell2,574.0016.3141,978.8563,052.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005413/0001562180-19-005413-index.htm
2020-04-09Karen ValentineOfficerBuy635.008.765,562.60635.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020002991/0001562180-20-002991-index.htm
2019-10-23James E AudiaDirectorSell200.0015.153,029.0263,822.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005221/0001562180-19-005221-index.htm
2019-10-22James E AudiaDirectorSell5,012.0015.0175,213.0864,022.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005221/0001562180-19-005221-index.htm
2019-11-06Emma ReeveChief Financial OfficerBuy9,084.007.6069,038.4065,626.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005413/0001562180-19-005413-index.htm
2020-05-06Patrick TrojerChief Scientific OfficerBuy7,164.007.6054,446.407,164.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003454/0001562180-20-003454-index.htm
2020-02-11Emma ReeveChief Financial OfficerBuy7,212.007.6054,811.207,212.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001123/0001562180-20-001123-index.htm
2019-11-06Emma ReeveChief Financial OfficerSell15,740.0029.75468,260.28726.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005413/0001562180-19-005413-index.htm
2020-04-17Emma ReeveChief Financial OfficerBuy760.006.615,023.60760.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003063/0001562180-20-003063-index.htm
2019-11-06Jigar RaythathaOfficerSell20,550.0025.06514,952.1876,611.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005409/0001562180-19-005409-index.htm
2020-04-20Karen ValentineOfficerBuy789.0011.509,073.50789.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020003096/0001562180-20-003096-index.htm
2019-10-22Patrick TrojerChief Scientific OfficerSell9,985.0015.00149,801.968,222.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005222/0001562180-19-005222-index.htm
2019-10-23Patrick TrojerChief Scientific OfficerSell300.0015.204,559.048,222.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005222/0001562180-19-005222-index.htm
2019-11-04Patrick TrojerChief Scientific OfficerSell100.0015.001,500.008,222.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005371/0001562180-19-005371-index.htm
2019-11-05Patrick TrojerChief Scientific OfficerSell1,150.0015.0117,255.758,222.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005371/0001562180-19-005371-index.htm
2019-11-04Patrick TrojerChief Scientific OfficerBuy100.005.51551.008,322.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005371/0001562180-19-005371-index.htm
2019-11-06Patrick TrojerChief Scientific OfficerBuy195.004.08795.608,417.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005412/0001562180-19-005412-index.htm
2019-10-23Patrick TrojerChief Scientific OfficerBuy300.005.511,653.008,522.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005222/0001562180-19-005222-index.htm
2020-02-11Karen ValentineOfficerBuy8,550.0011.5098,325.008,550.00https://www.sec.gov/Archives/edgar/data/1434418/000156218020001122/0001562180-20-001122-index.htm
2018-12-13Adrian SenderowiczChief Medical OfficerBuy9,083.005.5150,047.339,083.00https://www.sec.gov/Archives/edgar/data/1434418/000089924318031227/0000899243-18-031227-index.htm
2019-11-06Patrick TrojerChief Scientific OfficerBuy801.005.514,413.519,218.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005412/0001562180-19-005412-index.htm
2019-11-05Patrick TrojerChief Scientific OfficerBuy1,150.005.516,336.509,372.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005371/0001562180-19-005371-index.htm
2019-11-06Jigar RaythathaOfficerSell3,170.0021.2067,198.2997,161.00https://www.sec.gov/Archives/edgar/data/1434418/000156218019005409/0001562180-19-005409-index.htm